US BANCORP \DE\ - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$23,000
-36.1%
19,6870.0%0.00%
Q2 2022$36,000
-18.2%
19,687
-10.0%
0.00%
Q1 2022$44,000
-25.4%
21,879
+2.2%
0.00%
Q4 2021$59,000
-42.7%
21,413
-6.5%
0.00%
Q3 2021$103,000
-10.4%
22,897
+15.2%
0.00%
Q2 2021$115,000
-19.6%
19,871
-2.5%
0.00%
Q1 2021$143,000
+4.4%
20,383
-28.4%
0.00%
Q4 2020$137,000
+3.0%
28,483
+24.4%
0.00%
Q3 2020$133,000
-21.8%
22,903
-8.8%
0.00%
Q2 2020$170,000
+8.3%
25,101
+1.6%
0.00%
Q1 2020$157,000
-38.7%
24,699
+0.8%
0.00%
-100.0%
Q4 2019$256,000
+1180.0%
24,500
+390.0%
0.00%
Q3 2019$20,000
-87.8%
5,000
-54.5%
0.00%
Q2 2019$164,000
-25.1%
10,991
+24.6%
0.00%
-100.0%
Q1 2019$219,000
+50.0%
8,820
+8.4%
0.00%
Q4 2018$146,000
-18.0%
8,139
+34.2%
0.00%
-100.0%
Q3 2018$178,000
-26.7%
6,064
+13.2%
0.00%0.0%
Q2 2018$243,000
-17.9%
5,355
-4.2%
0.00%0.0%
Q1 2018$296,000
+622.0%
5,589
+819.2%
0.00%
Q4 2017$41,000
+20.6%
608
+47.2%
0.00%
Q3 2017$34,000
+325.0%
413
+339.4%
0.00%
Q2 2017$8,000
+100.0%
94
+54.1%
0.00%
Q1 2017$4,000
-89.2%
61
-94.2%
0.00%
Q4 2015$37,000
-47.9%
1,059
+37.5%
0.00%
Q3 2015$71,000
-47.0%
770
-49.8%
0.00%
-100.0%
Q2 2015$134,000
+22.9%
1,534
+4.5%
0.00%
Q1 2015$109,000
+41.6%
1,468
+6.7%
0.00%
Q4 2014$77,000
+71.1%
1,376
+40.0%
0.00%
Q3 2014$45,0009830.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders